TARDBP

Chr 1

TAR DNA binding protein

Also known as: ALS10, TDP-43

HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. A similar pseudogene is present on chromosome 20. [provided by RefSeq, Jul 2008]

GeneReviewsResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.28
Clinical SummaryTARDBP
🧬
Gene-Disease Validity (ClinGen)
amyotrophic lateral sclerosis type 10 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.99). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
26 unique Pathogenic / Likely Pathogenic· 192 VUS of 387 total submissions
💊
Clinical Trials
4 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — TARDBP
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.28LOEUF
pLI 0.985
Z-score 3.62
OE 0.06 (0.020.28)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.71Z-score
OE missense 0.32 (0.260.39)
74 obs / 233.5 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.06 (0.020.28)
00.351.4
Missense OE?0.32 (0.260.39)
00.61.4
Synonymous OE?1.10
01.21.6
LoF obs/exp: 1 / 17.2Missense obs/exp: 74 / 233.5Syn Z: -0.75

This gene — mechanism propensity

DN
0.4587th %ile
GOF
0.3689th %ile
LOF
0.75top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.28
GOF1 literature citation · 96% of P/LP are missense

Literature Evidence

GOFThese results suggest a toxic gain of function or dominant negative effect of mutant TDP-43.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 18309045

ClinVar Variant Classifications

387 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic17
VUS192
Likely Benign108
Benign27
Conflicting16
9
Pathogenic
17
Likely Pathogenic
192
VUS
108
Likely Benign
27
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
9
0
0
9
Likely Pathogenic
1
16
0
0
17
VUS
7
131
51
3
192
Likely Benign
0
7
38
63
108
Benign
0
1
23
3
27
Conflicting
16
Total816411269369

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

40 pathogenic / likely-pathogenic (of 57) ClinVar copy-number / structural variants overlap TARDBP — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TARDBP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.